[Psychiatric disorders after a single 3,4-methylenedioxyethamphetamine (MDE, "Eve") and tetrahydrocannabinol (cannabis) use].
We report on a single intake of 3,3-methylenedioxyethamphetamine (MDE, "Eve") and tetrahydrocannabinol (cannabis). Because of the increasing abuse of "designer-drugs" and the rare reports on MDE the psychopathology after intake of MDE and cannabis is presented.
Assion
H J
HJ
Neurologische Abteilung, St.-Josef-Krankenhaus Moers, Oberhausen.
Heinemann
F
F
D015104:3,4-Methylenedioxyamphetamine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000328:Adult; D015198:Designer Drugs / Q000009:adverse effects*; D013759:Dronabinol / Q000009:adverse effects*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D011605:Psychoses, Substance-Induced / Q000175:diagnosis* / Q000523:psychology
D015198:Designer Drugs; D015104:3,4-Methylenedioxyamphetamine; D013759:Dronabinol; C051800:3,4-methylenedioxyethamphetamine